SCHEMBL21311210

SCHEMBL21311210

COc1ccc(S(=O)(=O)NCC2OCC(O)(n3cnc4c(N)ncnc43)C2O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20097184 0.92 — —
SCHEMBL21311472 0.84 CHKA (0.41) —
SCHEMBL22837883 0.77 ADORA3 (0.37) —
SCHEMBL20097181 0.77 — —
SCHEMBL21311217 0.77 ADORA2A (0.47) —
SCHEMBL22837900 0.76 ADORA3 (0.36) —
SCHEMBL23025515 0.76 ADORA3 (0.53) —
SCHEMBL25521510 0.76 ADORA3 (0.53) —
SCHEMBL21311216 0.76 ADORA2A (0.47) —
SCHEMBL22837884 0.75 GMPS (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190262371-A1 METHODS AND COMPOSITION FOR THE TREATMENT OF RNA VIRAL INFECTIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-08-29 — — US disclosed
Send feedback